Skip to main content
. 2013 Feb 18;28(2):147–153. doi: 10.1177/1533317512475021

Table 2.

Differences in Baseline Characteristics Between the Combined Criteria Group (MEC <24 or a Drop of More Than 4 Points in MEC Score Over the Follow-Up Period) and the Group With No Cognitive Impairment at Follow-Up.

New Cognitive Decline (n = 59) No Cognitive Impairment (n = 110) P Value
Gender .43
 Male, n (%) 20 (33.9) 44 (40)
 Female, n (%) 39 (66.1) 66 (60)
Marital status .99
 Married, n (%) 27 (45.8) 51 (46.4)
 Single, n (%) 3 (5.1) 6 (5.5)
 Widowed, n (%) 29 (49.2) 53 (48.2)
Education .03
 None or only primary, n (%) 51 (86.4) 79 (71.8)
 Secondary or university level, n (%) 8 (13.6) 31 (28.2)
Living alone, n (%) 21 (35.6) 33 (30) .45
Barthel Index, mean ± SD 89.2 ± 16 94.9 ± 10 .006
MEC, mean ± SD 29.4 ± 3.2 30.7 ± 2.9 .01
MNA, mean ± SD 25.2 ± 3.6 26 ± 2.7 .16
Gijon questionnaire, mean ± SD 9.4 ± 2.5 9.1 ± 2.4 .54
Falls, mean number ± SD 0.6 ± 1.6 0.2 ± 0.5 .03
Charlson score, mean ± SD 1.07 ± 1.1 1.1 ± 1.3 .84
Hypertension, n (%) 46 (78) 85 (77.3) .91
Diabetes mellitus, n (%) 14 (23.7) 12 (10.9) .03
Dyslipidemia, n (%) 31 (52.5) 56 (50.9) .82
Previous stroke, n (%) 7 (11.9) 15 (13.6) .74
Anemia, n (%) 7 (11.9) 17 (15.5) .52
Heart failure, n (%) 7 (11.9) 10 (9.1) .56
Atrial fibrillation, n (%) 9 (15.3) 7 (6.4) .06
Ischemic cardiomyopathy, n (%) 3 (5.1) 6 (5.5) .91
Number of drugs taken, mean ± SD 5.9 ± 2.9 5.5 ± 3 .21
EuroQol-5D/EQ-VAS, mean ± SD 64.1 ± 19 67.8 ± 19 .21
Serum 25(OH)D (ng/mL), mean ± SD 24.9 ± 14 26.2 ± 13 .57
Total cholesterol (mg/dL), mean ± SD 200.1 ± 36 193.7 ± 35 .26
Thyrotropin (mU/L), mean ± SD 3.1 ± 4 2.6 ± 2 .33
Folic acid (nmol/L). mean ± SD 23.3 ± 9 22 ± 10 .56
Vitamin B12 (pmol/L) mean ± SD 328 ± 208 331 ± 195 .92

Abbreviations: MEC, Spanish version of the Mini-Mental State Examination; MNA, Mini Nutritional Assessment; EuroQol-5D/EQ-VAS, measure of quality of life with a visual analogue scale; SD, standard deviation; 25(OH)D, 25-hydroxy vitamin D.